Mengjie Chen

Mengjie Chen

Auto-generated profile, based on publicly available information

Mengjie Chen

University of Chicago

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2022 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
LHLulu Hu
Lulu Hu
SLShun Liu
Shun Liu
YPYong Peng
Yong Peng
RGRuiqi Ge
Ruiqi Ge
RSRui Su
Rui Su
CHChuan He
Chuan He

17 February 2023 in Science
Verified
Journal Article
Open access
PHP. Cody He
P. Cody He
JWJiangbo Wei
Jiangbo Wei
XDXiaoyang Dou
Xiaoyang Dou
BHBryan T. Harada
Bryan T. Harada
ZZZijie Zhang
Zijie Zhang
CHChuan He
Chuan He
N 6 -methyladenosine (m 6 A) is the most abundant messenger RNA (mRNA) modification and plays crucial roles in diverse physiological processes. Using a massively parallel assay for m 6 A (MPm 6 A), we discover that m 6 A specificity is globally regulated by suppressors that prevent m 6 A deposition in unmethylated transcriptome regions. We identify exon junction complexes (EJCs) as m 6 A suppressors that protect exon junction–proximal RNA within coding sequences from methylation and regulate mRNA stability through m 6 A suppression. EJC suppression of m 6 A underlies multiple global characteristics of mRNA m 6 A specificity, with the local range of EJC protection sufficient to suppress m 6 A deposition in average-length internal exons but not in long internal and terminal exons. EJC-suppressed methylation sites colocalize with EJC-suppressed splice sites, which suggests that exon architecture broadly determines local mRNA accessibility to regulatory complexes.

26 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
JCJiang Chang
Jiang Chang
WTWenle Tan
Wenle Tan
ZLZhiqiang Ling
Zhiqiang Ling
RXRuibin Xi
Ruibin Xi
MSMingming Shao
Mingming Shao
DLDongxin Lin
Dongxin Lin
Approximately half of the world’s 500,000 new oesophageal squamous-cell carcinoma (ESCC) cases each year occur in China. Here, we show whole-genome sequencing of DNA and RNA in 94 Chinese individuals with ESCC. We identify six mutational signatures (E1–E6), and Signature E4 is unique in ESCC linked to alcohol intake and genetic variants in alcohol-metabolizing enzymes. We discover significantly recurrent mutations in 20 protein-coding genes, 4 long non-coding RNAs and 10 untranslational regions. Functional analyses show six genes that have recurrent copy-number variants in three squamous-cell carcinomas (oesophageal, head and neck and lung) significantly promote cancer cell proliferation, migration and invasion. The most frequently affected genes by structural variation are LRP1B and TTC28. The aberrant cell cycle and PI3K-AKT pathways seem critical in ESCC. These results establish a comprehensive genomic landscape of ESCC and provide potential targets for precision treatment and prevention of the cancer.

2 January 2023 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
YXYu-Lan Xiao
Yu-Lan Xiao
SLShun Liu
Shun Liu
RGRuiqi Ge
Ruiqi Ge
YWYuan Wu
Yuan Wu
CHChuan He
Chuan He
WTWeixin Tang
Weixin Tang

26 February 2018 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
MSMarni B. Siegel
Marni B. Siegel
XHXiaping He
Xiaping He
KHKatherine A Hoadley
Katherine A Hoadley
AHAlan Hoyle
Alan Hoyle
JPJulia B. Pearce
Julia B. Pearce
CPCharles M Perou
Charles M Perou
Breast cancer metastasis remains a clinical challenge, even within a single patient across multiple sites of the disease. Genome-wide comparisons of both the DNA and gene expression of primary tumors and metastases in multiple patients could help elucidate the underlying mechanisms that cause breast cancer metastasis. To address this issue, we performed DNA exome and RNA sequencing of matched primary tumors and multiple metastases from 16 patients, totaling 83 distinct specimens. We identified tumor-specific drivers by integrating known protein-protein network information with RNA expression and somatic DNA alterations and found that genetic drivers were predominantly established in the primary tumor and maintained through metastatic spreading. In addition, our analyses revealed that most genetic drivers were DNA copy number changes, the TP53 mutation was a recurrent founding mutation regardless of subtype, and that multiclonal seeding of metastases was frequent and occurred in multiple subtypes. Genetic drivers unique to metastasis were identified as somatic mutations in the estrogen and androgen receptor genes. These results highlight the complexity of metastatic spreading, be it monoclonal or multiclonal, and suggest that most metastatic drivers are established in the primary tumor, despite the substantial heterogeneity seen in the metastases.

12 November 2018 in Genome Biology
Verified
Journal Article
Open access
PDF file
MCMengjie Chen
Mengjie Chen
XZXiang Zhou
Xiang Zhou
We develop a method, VIPER, to impute the zero values in single-cell RNA sequencing studies to facilitate accurate transcriptome quantification at the single-cell level. VIPER is based on nonnegative sparse regression models and is capable of progressively inferring a sparse set of local neighborhood cells that are most predictive of the expression levels of the cell of interest for imputation. A key feature of our method is its ability to preserve gene expression variability across cells after imputation. We illustrate the advantages of our method through several well-designed real data-based analytical experiments.